Explore more publications!

Business Times DC: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Times DC.

Press releases published on January 7, 2026

DBIA Announces Region Relations Leadership Team to Support Design-Build Growth Nationwide
Capitol Physical Therapy Unveils New Insights on Meniscus Tears and Knee Injury Recovery
Saxena White P.A. Files Securities Fraud Class Action Against Coupang, Inc., Certain of Its Executives, and Coupang Corp., Expanding the Class Period and Allegations Asserted in Related Action
THEON completes the acquisition of a circa 9.8% stake in Exosens
DEADLINE ALERT for BTDR, GAUZ, ITGR, FFIV: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Asia Forex Mentor Announces AFM Trading Summit Live 2026 – A Free Flagship Global Online Event Setting the 2026 Playbook for Traders and Investors
Transaction in Own Shares

Transaction in Own Shares

SIA and Bullhorn Announce New IT Staffing Indicator
THE CHOKE POINT: 5 Assets That Control the Bottleneck
Global Card Fraud Losses at $33 Billion
300 Exceptional Teen Scientists Recognized for Innovative STEM Research in Nation’s Oldest and Most Prestigious High School Competition
AB Science annonce un quatrième cas consécutif de réponse avec la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute, sur la base des données de phase 1
AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
GENFIT Announces 2026 Financial Calendar
GENFIT annonce son calendrier financier pour 2026
Bronstein, Gewirtz & Grossman LLC Urges F5, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Abstrax Releases 2026 Cannabis Flavor & Application Trends to Guide Product Innovation and Portfolio Growth
VALLOUREC INITIATES A €200 MILLION SHARE BUYBACK AND TARGETS TOTAL SHAREHOLDER RETURN TO BE AT LEAST €500 MILLION BY AUGUST 2026
VALLOUREC LANCE UN PROGRAMME DE RACHAT D’ACTIONS DE 200MILLIONS D’EUROS ET VISE UN RETOUR TOTAL AUX ACTIONNAIRES D’AU MOINS 500MILLIONS D’EUROS D’ICI AOUT 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions